Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03048617 · ClinicalTrials.gov registry record
An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)
A clinical trial, sponsored by Stealth BioTherapeutics.
- Completed
- Registry status
- 215
- Enrollment target
NCT03048617 is a clinical trial that has completed, run by Stealth BioTherapeutics. The registered enrollment target is 215 participants.
The verdict
NCT03048617 has completed, sponsored by Stealth BioTherapeutics.
- COMPLETED
- Registry status
- 215 participants
- Enrollment target
Study Summary
This is an observational study of patients with Primary Mitochondrial Disease with either signs or symptoms suggestive of myopathy. The Investigator will identify potential patients through existing medical records and one on-site visit.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2019-03-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03048617
The ClinicalTrials.gov registry entry for NCT03048617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stealth BioTherapeutics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03048617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03048617 about?
NCT03048617 is a clinical study titled "An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)". This is an observational study of patients with Primary Mitochondrial Disease with either signs or symptoms suggestive of myopathy. The Investigator will identify potential patients through existing medical records and one on-site visit.
What is the current status of trial NCT03048617?
This trial is currently completed. The enrollment target is 215 participants. The study started on 2017-02-13. Estimated completion is 2019-03-07.
Who is sponsoring clinical trial NCT03048617?
This trial is sponsored by Stealth BioTherapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.